Description
A mixture of LacCers isolated from bovine buttermilk with variable N-acyl chain lengths; expressed on the plasma membrane of human phagocytes; mediates phagocytosis, chemotaxis, and superoxide generation; forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors; elevated levels in kidney cortex homogenates and urine are directly correlated with hyperglycemia, insulin resistance, and obesity in db/db transgenic diabetic mice; promotes recruitment of CNS-infiltrating monocytes and microglia, and enhances neurodegeneration in mice with chronic EAE, a model of MS; correlated with increased levels of pro-inflammatory cytokines IL-6, MCP-1, and MIP-1β, as well as lipids and macrophages in atherosclerotic plaques
Formal name: 1-O-(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)-ceramide
Synonyms: LacCer
Molecular weight: 960.4
CAS: 4682-48-8
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Endocrinology & Metabolism|Reproductive Biology||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Neurodegenerative Disorders